M&A Deal Summary

Ardian Acquires Neopharmed Gentili

On November 28, 2018, private equity firm Ardian acquired life science company Neopharmed Gentili from Mediolanum Farmaceutici

Acquisition Highlights
  • This is Ardian’s 11th transaction in the Life Science sector.
  • This is Ardian’s 28th transaction in Italy.

M&A Deal Summary
Date 2018-11-28
Target Neopharmed Gentili
Sector Life Science
Buyer(s) Ardian
Sellers(s) Mediolanum Farmaceutici
Deal Type Divestiture

Target

Neopharmed Gentili

Milan, Italy
Neopharmed Gentili is an Italian pharmaceutical group focused on the research, development, production, and distribution of medicines in many therapeutic areas such as vascular and cardio-metabolic areas, pneumatological areas, antibiotics, OTCs, and supplements. Neopharmed Gentili was founded in 2011 and is based in Milan, Italy.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Ardian

Paris, France

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1996
PE ASSETS 125.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Ardian is a mega-sized diversified investment group focused on opportunities worldwide. Ardian invests across and manages funds focused on small and mid-sized buyouts, growth capital financings, mezzanine, infrastructure, real estate, and co-investment opportunities. Ardian's small-buyouts group targets controlling interests in French, German, and Italian businesses valued up to €100 million. It's mid-sized buyout group seeks businesses valued up €1.5 billion and does not have any geographic limitations. The Infrastructure team looks for European opportunities and can commit up to €150 million per transaction. The Mezzanine group supports junior capital commitments of €5 to €80 million. In addition to direct investing, Ardian also manages various private equity fund-of-funds. Ardian was founded in 1996 and is based in Paris.

DEAL STATS #
Overall 327 of 418
Sector (Life Science) 11 of 16
Type (Divestiture) 25 of 30
Country (Italy) 28 of 33
Year (2018) 21 of 22
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-11-22 Technology & Strategy Group

Schiltigheim, France

Technology & Strategy Group specializes in engineering, IT, digital, and project management consulting and works closely with its clients to address a wide range of technological challenges. Technology & Strategy Group was founded in 2008 and is based in Schiltigheim, France.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-12-10 Cast & Crew

Burbank, California, United States

Cast & Crew is a provider of software and services to the entertainment production industry. Cast & Crew's software products and services assist in the areas of payroll & human resources, accounting & financial, and workflow & productivity. Cast & Crew was founded in 1976 and is based in Burbank, California.

Buy -

Seller(S) 1

SELLER

Mediolanum Farmaceutici

Milan, Italy
Category Company
Founded 1972
Sector Life Science
DESCRIPTION

Mediolanum Farmaceutici is a pharmaceutical company focused on serving customers from the Italian cardiovascular market. Mediolanum Farmaceutici was founded in 1972 and is based in Milan, Italy.

DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Divestiture) 1 of 1
Country (Italy) 1 of 1
Year (2018) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-05-07 ElsaLys Biotech SA

Lyon, France

ElsaLys Biotech SA is a provider of novel treatment solutions to patients, with a particular focus on whom the current therapies are less or no longer beneficial. ElsaLys Biotech is based in Lyon, France.

Buy -
Mergr

Product

Company

Legal